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Abstract
Background: The present study (1) examined patient satisfaction with care over the first year following the
diagnosis of advanced breast cancer and (2) tested if unmet health system and information needs, physical
symptom distress, and psychological distress predicted patient satisfaction.
Methods: Prospective study of 213 Chinese women with advanced breast cancer assessed while awaiting or
receiving initial chemotherapy (baseline), then again at 1.5-, 3-, 6-, and 12-months post-baseline. Health system and
information unmet (HSI) needs, psychological distress, physical symptom distress, and patient satisfaction were
assessed at baseline; patient satisfaction was reassessed at each follow-up assessment. Latent growth curve analysis
assessed changes in patient satisfaction over the 12 months follow-up; hierarchical multiple regression analysis
tested if baseline health system information needs, physical symptom distress, anxiety and depression predicted
patient satisfaction at one-year post-baseline.
Results: The level of patient satisfaction was high and did not change significantly over time. Only HSI needs
(β = − 0.27, p < 0.005) significantly associated with baseline patient satisfaction. Patient satisfaction at one-year
post-baseline was predicted by HSI needs (β = − 0.26, p < 0.005), Anxiety (β = 0.23, p < 0.05) and Depression
(β = − 0.28, p < 0.005), adjusting for the effect of baseline patient satisfaction (β = 0.22, p < 0.005).
Conclusions: Unmet health information needs and greater depressive symptoms at initial treatment phased
predicted subsequent poorer patient satisfaction. This highlights a need to reinforce the importance of
patient-centered care model in managing advanced breast cancer.
Keywords: Patient satisfaction, Advanced breast cancer, Chinese, Unmet information needs, Psychological distress
Background
Patient satisfaction is an important indicator of quality
health care [1]. High patient satisfaction has been linked
to better practice guideline adherence and lower in-
patient mortality rates [2], as well as to greater patient ac-
ceptance and adherence to prescribed medical care [3, 4].
Patient satisfaction as an outcome measure is particularly
important for patients diagnosed with a chronic or life-
threatening condition, such as cancer, who require
ongoing medical care to manage the condition. Numerous
studies have examined patient satisfaction in oncology
settings [5]. The level of patient satisfaction reported in
these studies was generally high [5, 6]. Previous studies
also examined factors associated with patient satisfaction
including patient factors, such as age, gender, and type of
cancer, and patient care factors, including information
provision, doctor-patient relationship, and continuity of
care. However, there is little consistency in reported asso-
ciations between demographic factors and patient satisfac-
tion [5]. In contrast, patient care factors, particularly
information provision [5, 7], and a patient-centered con-
sultation style [8–10] were important predictors of patient
satisfaction. Furthermore, there is evidence that patient
* Correspondence: wwtlam@hku.hk
1Centre for Psycho-Oncology Research & Training, Division of Behavioural
Sciences, School of Public Health, The University of Hong Kong(HKU), 5/F,
WMW Mong Block, Faculty of Medicine Building, 21 Sassoon Road, Pokulam,
Hong Kong
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lam et al. BMC Cancer  (2018) 18:162 
https://doi.org/10.1186/s12885-018-4085-3
satisfaction might be hampered by unresolved physical
symptom distress [11] and psychological distress [12].
While cancer patients are not one homogenous group,
existing evidence for satisfaction is primarily based on
studies of mixed cancer types. It is, therefore, important
to examine patient satisfaction across types of cancer.
There is little information on patient satisfaction
among women with advanced breast cancer. Advanced
breast cancer includes both metastatic disease and lo-
cally advanced disease. Treatment advances have in-
creased life expectancy for women with metastatic
breast cancer, resulting a growing numbers of affected
women living with the illness [13]. While treatment pro-
longs these women’s lives, disease progression is often
inevitable and ongoing treatments impose various
threats including side-effects, uncertainty, and fear of
death. In contrast, locally-advanced breast cancer is a
potentially-curable condition, but the prognosis is gener-
ally poor with a five-year survival of less than 50% [14].
Threats of cancer recurrence and aggressive cancer
treatment side-effects put additional demands on af-
fected women. Due to the nature of the disease, women
with advanced breast cancer are likely to require on-
going cancer care. Hence, it is important to examine
how such women assess their cancer care services. The
current study aimed to examine patient satisfaction with
care over the first year and its predictors in women fol-
lowing the diagnosis of advanced breast cancer, here, de-
fined as metastatic breast cancer or regional disease
spread. As previous studies have shown doctor-patient
communication [5, 7] and patient-centered models of
care [8–10] influenced patient satisfaction, we tested if
patients’ disease and treatment information-related
needs at baseline influenced subsequent patient satisfac-
tion. We also tested if greater physical symptom distress
[11] and psychological distress [12] at baseline predicted
subsequent patient satisfaction.
Methods
Following ethical committee approval for multi-center
studies, Cantonese/Mandarin-speaking Chinese women
newly diagnosed with stage III locoregional or stage IV
metastatic breast cancer awaiting or receiving initial
chemotherapy were recruited consecutively from six
Hong Kong public oncology/breast cancer out-patient
clinics between September 2008 and October 2012.
Women with linguistic or intellectual difficulties were
excluded from the study. At each hospital, potential pa-
tients were identified by clinical oncologists/surgeons. A
trained research assistant then approached the potential
patients immediately while they were awaiting their con-
sultation. After explanations of the study, written con-
sent was obtained from those who agreed to participate.
Participants then completed a standardized baseline
face-to-face questionnaire-based interview. Face-to-face
follow-up assessments were then conducted at 6 weeks,
3-, 6-, and 12-months post-baseline at the oncology out-
patient clinic.
Measures
Patient satisfaction was assessed using the Nine-item
Chinese Patient Satisfaction Questionnaire (ChPSQ-9)
[15]. This measure was designed for assessing patient sat-
isfaction with the specialist out-patient services provided
by doctors, nurses, and other medical staff in the Chinese
population [16]. The ChPSQ-9 primarily assessed the
interpersonal, caring aspects of health care providers. It
has been validated in the local cancer population includ-
ing patients with breast cancer [15, 17]. Each item is rated
on a 5-point Likert scale from “very dissatisfied” [1] to
“very satisfied” [5]. Total scores range from 9 to 45, with
higher scores indicating greater satisfaction. The ChPSQ-9
demonstrated good internal consistency, with Cronbach’s
alpha ranged from 0.88 to 0.93.
The Chinese version of the Supportive Care Needs
Survey Short Form (SCNS-SF 34-C) was used to assess type
and magnitude of unmet needs [18–20]. The SCNS-SF 34
has been widely used and validated for use in cancer pa-
tients. This measure has good content validity and internal
reliability (Cronbach’s alpha 0.82 to 0.92) [18, 19] and mea-
sures patients’ perceived need for help in five need do-
mains: Health system and information (HSI) (11 items);
Psychological (10 items); Physical and daily living (5 items);
Sexuality (3 items); Patient care and support (5 items). Pa-
tients rate the intensity of each need over the past month
for each item using five-point Likert scales: 1. No need: not
applicable; 2. No need: satisfied; 3. Low need; 4. Moderate
need; 5. High need. Scores were converted to standardized
Likert summated scores ranging from 0 to 100 when calcu-
lating domain scores, with higher scores indicating greater
perceived unmet need [20]. In the present study, the HSI
subscale was used to assess patients’ disease and treatment
information-related needs.
Psychological distress was measured by the 14-item
Hospital Anxiety and Depression Scales (HADS) [21],
comprised of 2 seven-item subscales that measure symp-
toms of anxiety and depression. Each item is rated on a
four-point scale. Total scores for each subscale range
from 0 to 21, with higher scores indicating greater dis-
tress. Scores exceeding 10 on each subscale constitute
case definition for psychological morbidity, scores of
8–10 indicate subclinical caseness and scores < 8 repre-
sent non-cases. The Chinese version of the HADS has
been widely used among cancer patients and has good val-
idity [22]. Both anxiety (Cronbach’s α 0,86) and depression
(Cronbach’s α 0.82) scales demonstrate good internal
consistency. The HADS is suitable for use in cancer as it
omits items addressing common vegetative symptom
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changes, such as fatigue or weight change, arising
from physical illness which otherwise would inflate
apparent depression and anxiety symptom prevalence
in medical populations.
Physical symptom distress was measured using the
Chinese version of the Memorial Symptom Assessment
Scale Short-Form (MSAS-SF) a measure of 28 physical
and 4 psychological symptoms commonly experienced
by cancer patients [23, 24]. Patients indicate if they have
experienced the listed symptoms over the past week and,
if so, rate the intensity of distress (five-point Likert scale)
from each symptom. The MSAS-SF consists of four sub-
scales: a Global Distress Index, Physical symptom dis-
tress score, psychological symptom distress score, and
the Total MSAS score [23, 24]. The MSAS-SF has been
widely used and validated in cancer patients, the Chinese
version having been validated in the local cancer popula-
tion [23] the subscales demonstrating good internal
consistency, with Cronbach’s alpha ranging from 0.84 to
0.91. In the present study, the Physical symptom distress
subscale was used to assess physical symptom distress.
Patients’ socio-demographic data were collected at
baseline interview, whereas clinical data were extracted
from patients’ medical record using a standard protocol.
In the present study, all of the above measures were
assessed at baseline, with patient satisfaction again mea-
sured at each subsequent follow-up assessment.
Statistical analysis
Standard descriptive analyses assessed sample characteris-
tics. We initially used latent growth curve (LGC) analysis
for assessing the change of patient satisfaction over the
12 months’ follow-up. LGC analysis estimated the initial
level of patient satisfaction and the associated slope, the
rate of change in patient satisfaction scores. The analysis
showed that level of patient satisfaction did not change
significantly over time (data not shown). In this paper, we
therefore reported the prediction of patient satisfaction at
one-year post-baseline. Several variables, including health
system and information needs and physical symptom dis-
tress consistently predict subsequent psychosocial distress
[25, 26]. It seems likely that distressed patients would be
less satisfied. Consequently, we used hierarchical multiple
regression analysis to examine if baseline health system in-
formation needs, physical symptom distress, anxiety and
depression also predicted patient satisfaction one-year
post-baseline. The first block (model 1) entered in the
hierarchical model consisted of significant demographic
and clinical variables. In the second block (model 2), base-
line patient satisfaction was entered. The third block
(model 3) consisted of baseline health system information
needs, physical symptom distress, anxiety and depression.
All analyses reported in this paper were conducted using
SPSS Statistics version 21.
Results
Of 380 eligible women approached for recruitment, 20
were excluded due to linguistic or functional incapacity,
and 317/360 (88%) gave informed consent and completed
the interview (Fig. 1). With the exception of age, women
refusing or lost to follow-up did not differ by demographic
or medical factors, nor in their responses to the study vari-
ables at baseline. Women refusing or lost to follow-up
were significantly older (mean 55.5 years old vs. 52 years
old, t = − 2.28, p = 0.025) than those who completed the
follow-up assessments. A total of 39 (11%) participants
died during the study period. Compared to women who
survived, those who died during the study were more
likely to have recurrent breast cancer (71% vs. 40.9%,
p = 0.002), have metastatic disease (71% vs. 50.2%, p = 0.03)
and greater physical symptom distress scores (mean 1.08
vs. 0.56, t = 2.83, p = 0.008). For women who survived
(n = 278) the duration of the study, 213 (77%) successfully
completed the one-year post-baseline assessment. Hereafter,
Assessed for eligibility (n=380)
Excluded  (n= 20)
Refused (n = 43)
Baseline assessment completed (n=317)
FU 1 assessment completed (n=255)
Lost to follow-up (n=43); Refused (n=17); Deceased (n=3)
FU2  assessment completed (n=251)
Lost to follow up (n=29); Refused (n=32); Deceased (n=6)
FU3  assessment completed (n=245)
Lost to follow up (n=20); Refused (n=42); Deceased (n=11)
FU4  assessment completed (n=213)
Lost to follow up (n=11); Refused (n=55); Deceased(n=39)
Analysed  (n=213)
Excluded from analysis (Lost to follow up at FU4 (n=11); 
Refused (n=55); Deceased n= 39)
Fig. 1 Sampling structure and attrition pattern of the study
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the descriptions of the baseline data and multivariate
analysis examining predictors of patient satisfaction
are based on data from these 213 women who com-
pleted the one-year post-baseline assessment. Table 1
summarizes the demographic and clinical characteris-
tics of the study sample.
Patient satisfaction, health system information needs,
physical symptom and psychological distress
The mean total PSQ scale score was 34.97 (SD5.29) at
baseline and 35.30 (SD4.69) at one-year post-baseline,
suggesting the level of patient satisfaction was high and
stable (Table 1). Repeated measure analysis showed no
significant difference of patient satisfaction between
baseline and follow-up assessments (F = 0.47, p = 049).
The mean baseline SCNS Health system information
needs score was 35.43 (SD 11.24), indicating a moderate
level of unmet need regarding disease and treatment-
related information and continuity of care. In contrast,
the mean scores on the MSAS measure of physical
symptom distress (mean 0.51, SD 0.37), HADS anxiety
(mean 3.95, SD 3.93), and HADS depression (mean 3.87,
SD 3.86) suggested low levels of physical symptom and
psychological distress at baseline.
Predictors of patient satisfaction
Linear regression analyses showed patient satisfaction at
12-months post-baseline was not significantly associated
with patients’ demographic and clinical characteristics.
Therefore, only baseline patient satisfaction (PSQ-9), pa-
tient disease and treatment-related health service and in-
formation needs (HSI needs), physical symptom distress
(MSAS physical symptom distress), and psychological
distress (HADS Anxiety and HADS Depression) were in-
cluded in the subsequent hierarchical multiple regres-
sion analysis (Table 2). After adjusting for the effect of
baseline PSQ-9, the inclusion of HSI needs increased the
variance by an additional 5% (β = − 0.23, p < 0.005,
model 2). Baseline MSAS physical symptom distress
did not predict 12-months post-baseline PSQ scores
(model 3). In the final model, the inclusion of HADS
Anxiety (β = 0.23, p < 0.05, model 2) and Depression
(β = − 0.28, p < 0.005) accounted only for an additional
3% of variance. Baseline PSQ-9 and HSI significantly
predicted 12-month post-baseline PSQ. Adjusting for the
effect of baseline PSQ-9, patients indicating higher base-
line unmet disease and treatment-related needs and with
higher baseline depression (HADS-D) scores reported sig-
nificantly lower satisfaction at 1-year post-baseline,
whereas patients with higher baseline anxiety (HADS-A)
scores reported significantly greater 1-year post-baseline
satisfaction. Post-hoc power analysis was conducted using
G*Power 3.1. With an effect size of 0.14, a sample size of
213 and significance criteria of 0.05, the statistical power
Table 1 Baseline demographic, clinical, and study variables
measured for participants (n = 213)
Characteristics Participants (%)
Demographics
Age (years) mean ± standard deviation (SD) 52.03 ± 9.09
Marital status
Married/cohabiting 144 (67.6)
Single/divorced/separated/widowed 69 (32.4)
Education level
No/primary formal education 78 (36.6)
Secondary (completed high school)/
Tertiary (college/university)
135 (63.3)
Total monthly household income (HK$)a
< $10,000 74 (34.7)
$10,001–30,000 83 (39.0)
> $30,001 41 (19.3)
Missing 15 (7.0)
Occupation
Full-time/part-time occupation 71 (33.3)
Retired 22 (10.3)
Housewife 68 (31.9)
Unemployed before/after diagnosis 50 (23.5)
Missing 2 (1.0)
Clinical data
Recurrence of breast cancer
Yes 77 (36.2)
No 136 (63.8)
Metastasis of breast cancer
Yes 99 (46.5)
No 114 (53.5)
Time since current diagnosis (days)
Mean ± SD (median) 19.86 ± 49.14 (8)
Type of surgery
No surgery 68(31.9)
Breast conserving therapy 22 (10.3)
Modified radical mastectomy 113 (53.1)
Modified radical mastectomy plus reconstruction 10 (4.7)
Undergoing active treatment at baseline
Chemotherapy 22 (10.3)
Radiation therapy 17 (7.9)
Hormonal therapy 8 (3.7)
Targeted therapy 10 (4.7)
Study variables Mean (SD)
ChPSQ-9 baseline 34.97 (5.29)
ChPSQ-9 12-months post-baseline (n = 213) 35.30 (4.69)
SCNS HSI need domain baseline 35.43 (11.24)
MSAS Physical symptom distress subscale baseline 0.51 (0.37)
HADS Anxiety 3.95 (3.93)
HADS Depression 3.87 (3.86))
SD Standard deviation, HK$ Hong Kong dollars a1 US$ = 7.8 HK$
ChPHQ-9 Chinese Patient Satisfaction Questionnaire
SCNS HSI Supportive care need scale– Health system information need
MSAS Memorial Symptom Assessment Scale
HADS Hospital Anxiety and Depression Scale
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was 0.99, suggesting the sample size was sufficient to
detect a difference.
Because baseline satisfaction scores were such strong
predictors of subsequent satisfaction, we performed a
post-hoc cross-sectional analysis to identify correlates of
baseline PSQ-9 scores. Table 3 details factors associated
with baseline PSQ-9. Baseline patient satisfaction did
not associate with patients’ demographic or clinical char-
acteristics in linear regression analyses. Therefore, only
HSI needs, MSAS physical symptom distress, HADS
Anxiety and HADS Depression were included in the
post-hoc regression analysis. Only HSI need (β = − 0.27,
p < 0.005) was significantly associated with baseline
PSQ-9 scores. Patients with higher baseline unmet dis-
ease and treatment-related needs reported poorer pa-
tient satisfaction at baseline.
Discussion
The present study examined factors predicting patient
satisfaction during the first year following the diagnosis
of advanced breast cancer. Consistent with previous
studies on patient satisfaction [5], our study showed
most women diagnosed with advanced breast caner re-
ported high level of satisfaction with their care over the
duration of the study. The level of patient satisfaction
was quite stable over time.
Overall, the study results provide partial support for the
hypotheses. As hypothesized, greater perceived unmet
needs for disease and treatment-related information and
continuity of care during the initial treatment phase pre-
dicted subsequent poorer patient satisfaction. This con-
curred with previous studies that patient-centered models
of care predict higher patient satisfaction [5, 7–10, 27, 28].
Our findings also supported the hypothesis that patients
experiencing greater depressive symptoms were likely to
be dissatisfied with medical care [12]. Depressed patients
often hold negative views of themselves and the world and
therefore may appear generally dissatisfied [12]. Also,
depressed patients may be more dissatisfied as their
psychosocial issues are not being addressed during con-
sultation [12]. There is evidence that oncologists often fail
to provide much psychosocial support during consulta-
tions [9, 29].
Contrary to our hypothesis, women with more anxiety
symptoms reported greater subsequent patient satisfac-
tion. It may be that anxious patients were more likely to
raise their concerns with the oncologists, get answers
and therefore feel more satisfied with their medical care.
Despite efforts to the contrary, many oncologists seldom
actively explore and identify patients’ concerns, but will
usually appropriately respond to concerns raised by
patients [9]. Physical symptom distress did not predict
patient satisfaction. Previous studies showed patient dis-
satisfaction to be related to inadequate information
provision on managing physical symptoms, but not the
frequency of physical symptoms [11]. The results of the
post-hoc analysis we performed are consistent with this.
Satisfaction at baseline was inversely associated only
with HIS needs. These findings reiterate the importance
of addressing patients’ information and psychosocial
needs as much as physical needs. Lastly, our findings in-
dicated that patient demographic factors had little effect
on patient satisfaction. There is little consistent evidence
that patient demographic characteristics influence pa-
tient satisfaction [5].
This study has several limitations. First, we used a
generic measure of patient satisfaction, but one designed
for use in the specialist out-patient services that these
Table 2 Hierarchical multiple regression models predicting patient satisfaction at one-year post-baseline by predictors
Baseline Model 1 Model 2 Model 3 Model 4
β 95% CI β 95% CI β 95% CI β 95% CI
PSQ scores 0.30** 0.15, 0.38 0.21** 0.06, 0.31 0.22** 0.07, 0.32 0.21** 0.06, 0.31
SCNS Health System & Information need scores −0.23** −0.16, − 0.04 −0.25** − 0.17, − 0.05 −0.26** − 0.18, − 0.06
MSAS physical symptom distress scores 0.07 −0.55, 1.84 0.13 −0.23, 2,56
HADS Anxiety scores 0.23* 0.04, 0.50
HADS Depression scores −0.28** −0.60, −0.09
R2 0.08 0.13 0.14 0.17
R2 change 0.08 0.05 0.01 0.03
PSQ Patient Satisfaction Questionnaire, SCNS Supportive Care Needs Scale, MASA Memorial Symptom Assessment Scale, HADS Hospital Anxiety and Depression Scale
*p < 0.05; **p < 0.005
Table 3 Multiple regression model of patient satisfaction
at baseline
β 95% CI
SCNS Health System & Information need scores −0.27** −0.19, − 0.07
MSAS physical symptom distress scores −0.05 −1.79, 0.92
HADS Anxiety scores 0.12 −0.21, 0.24
HADS Depression scores −0.19 −0.47, 0.002
R2 0.38
SCNS Supportive Care Needs Scale, MASA Memorial Symptom Assessment
Scale, HADS Hospital Anxiety and Depression Scale
*p < 0.05; **p < 0.005
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patients attended. The measure assesses care provided
by doctors and also nurses, and emphasizes care-related
communications [15]. It may not capture all the issues
in relation to oncology care, such as more technical in-
formation. Future studies should consider using a more
oncology-specific patient satisfaction measure such as
Patient Satisfaction and Quality in Oncological Care
questionnaire [30]. Second, the baseline was assessed
only at the start of chemotherapy and therefore was
unable to examine prior patient satisfaction at the diag-
nostic phase.
Conclusions
We understand the present study to be the first longitu-
dinal study describing patient satisfaction among women
diagnosed with advanced breast cancer. The findings
highlight most of this sample of Chinese women with
advanced breast cancer were satisfied with their medical
care. However, high level of unmet health system and
information needs predicted longer-term poor patient
satisfaction. This highlights the need to reinforce the
importance of patient-centered care model in consultations
for managing advanced breast cancer.
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